Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 9,459 | 9,988 | 9,605 | 11,931 | 9,619 |
| Operating Income | -9,459 | -9,988 | -9,605 | -11,931 | -9,619 |
| Interest Expense | 1,392 | 1,478 | 1,458 | 1,455 | 1,468 |
| Other Income | 2,676 | 2,516 | 1,484 | 1,579 | 2,460 |
| Pre-tax Income | -8,175 | -8,950 | -9,579 | -11,807 | -8,627 |
| Net Income Continuous | -8,175 | -8,950 | -9,579 | -11,807 | -8,627 |
| Net Income | $-8,175 | $-8,950 | $-9,579 | $-11,807 | $-8,627 |
| EPS Basic Total Ops | -43.00 | -96.50 | -158.00 | -210.00 | -129.50 |
| EPS Basic Continuous Ops | -42.63 | -96.69 | -158.07 | -209.86 | -129.56 |
| EPS Diluted Total Ops | -43.00 | -96.50 | -158.00 | -210.00 | -129.50 |
| EPS Diluted Continuous Ops | -42.63 | -96.69 | -158.07 | -209.86 | -129.56 |
| EPS Diluted Before Non-Recurring Items | -87.00 | -96.50 | -158.00 | N/A | N/A |
| EBITDA(a) | $-9,091 | $-9,603 | $-9,229 | $-11,553 | $-9,237 |